Tissues were homogenized in DMEM and virus was titrated by focus-forming assay61 using the rabbit polyclonal antibody against SARS-CoV nucleocapsid protein (Rockland, 200-401-A50, 0

Tissues were homogenized in DMEM and virus was titrated by focus-forming assay61 using the rabbit polyclonal antibody against SARS-CoV nucleocapsid protein (Rockland, 200-401-A50, 0.5?g/ml) or by RT-qPCR after RNA extraction as described below. Histology and RNA ISH Virus-infected hamsters were euthanized and perfused extensively with Drofenine Hydrochloride PBS. as model, we perform a genome-wide CRISPR screen and identify several endosomal entry-specific regulators. Experimental validation of hits from the CRISPR screen shows that host factors regulating the surface expression of angiotensin-converting enzyme 2 (ACE2) affect entry of Sfull virus. Animal-to-animal transmission with the Sdel virus is reduced compared to Sfull in the hamster model. These findings highlight the critical role of the S1/S2 boundary of SARS-CoV-2 spike protein in modulating virus entry and transmission and provide insights into entry of coronaviruses. was not targeted. We confirmed that Drofenine Hydrochloride editing of these genes did not affect cell viability (Supplementary Fig.?4b). The gene-edited cells were infected with pseudovirus bearing the spike protein of Sdel virus or, as a control, the glycoprotein of vesicular stomatitis virus (VSV-G) (Fig.?3a, b). Consistent with data from the fully infectious Sdel virus, editing any of the selected genes markedly inhibited Sdel pseudovirus infection whereas only editing of some retromer-associated genes and the Arp2/3 complex significantly reduced the VSV-G pseudovirus infection (Fig.?3a, b). These results suggest that most of the genes identified act at the virus entry step and are specific to SARS-CoV-2. Notably, pseudovirus bearing the spike protein of SARS-CoV, which lacks the multiple basic residues at the S1/S2 junction as Sdel, exhibited a phenotype similar to Sdel pseudovirus and Sdel live virus (Fig.?3c). Editing of these genes, including those encoding CTSL, cholesterol transporters NPC1/2, WDR81/91, and TFE3, markedly reduced infection, suggesting that H3 Sdel and SARS-CoV may utilize similar entry machinery in this cell Drofenine Hydrochloride type (Fig.?3c). Intriguingly, these edited genes also significantly reduced the infection by pseudovirus bearing the spike protein of Middle East Respiratory Syndrome coronavirus (MERS-CoV) in A549-ACE2-DPP4 cells (Fig.?3d). Although the furin cleavage site is present at the S1/S2 boundary of MERS-CoV33, it preferentially enters the A549 cell via endosomal pathway as indicated by its sensitivity to E-64d inhibitor (Supplementary Fig.?2e). This is possibly due to the lack of proper protease to activate the plasma membrane fusion pathway in A549 cells for MERS-CoV. In sum, these results indicate that the host genes identified from CRISPR screen are required for the entry in A549 cells by pseudotyped SARS-CoV and MERS-CoV, and SARS-CoV-2 with deletion at the S1/S2 boundary. Open in a separate window Fig. 3 Genes identified are required for the endosomal cell entry of SARS-CoV-2, SARS-CoV, and MERS-CoV.aCd The selected genes were verified for the infection by pseudovirus bearing the spike protein of SARS-CoV-2 Sdel strain (a), the the glycoprotein of vesicular stomatitis virus (VSV-G) (b), the spike protein of SARS-CoV (c), or the spike protein of MERS-CoV (d) (two experiments; did not reduce infection (Fig.?3e), as the Sfull virus enters A549-ACE2 cells via an endosomal-independent pathway (demonstrated in Fig.?1d). Also, editing of that functions in endolysosomes had a negligible impact on Sfull Drofenine Hydrochloride virus infection (Fig.?3e). In general, editing of genes encoding complexes that regulate the retrieval and recycling of cargo significantly reduced infection, albeit to a lesser extent than observed with the Sdel live virus (Fig.?3e). U18666A, a cationic sterol, binds to the NPC1 protein to inhibit cholesterol export from the lysosome, resulting in impaired endosome trafficking, late endosome/lysosome membrane fusion34C36. U18666A has been shown to inhibit the S protein-driven entry of SARS-CoV, MERS-CoV, and the human coronaviruses NL63 and 229E, with the most efficient inhibition.